cardiology careers collections past issues search home
     

J Am Coll Cardiol, 2006; 47:827-834, doi:10.1016/j.jacc.2005.10.041 (Published online 6 February 2006).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marian, A. J.
Right arrow Articles by Lombardi, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marian, A. J.
Right arrow Articles by Lombardi, R.

Antifibrotic Effects of Antioxidant N-Acetylcysteine in a Mouse Model of Human Hypertrophic Cardiomyopathy Mutation

Ali J. Marian, MD, FACC*, Vinitha Senthil, PhD, Suet N. Chen, MS and Raffaella Lombardi, MD

Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, Texas


Figure 1
View larger version (61K):

[in a new window]
 
Figure 1 Plasma and myocardial levels of lipid peroxides. Myocardial (A) and plasma (B) levels of malondialdehyde (MDA) and 4-hydroxyalkenals (HAE) are depicted in non-transgenic (NTG) and cardiac troponin T-Q92 (cTnT-Q92) transgenic mice treated with placebo or with N-acetylcysteine (NAC). *p < 0.05 for pairwise comparisons.

 

Figure 2
View larger version (98K):

[in a new window]
 
Figure 2 Effect of NAC on CVF. Panels in 2A show representative high-magnification microscopic fields (x400) in non-transgenic (NTG), cTnT-Q92 mice treated with placebo and cTnT-Q92 mice treated with NAC. (B) Quantitative values in the three groups. *p < 0.05 for pairwise comparisons.

 

Figure 3
View larger version (57K):

[in a new window]
 
Figure 3 Expression levels of procollagen genes. Relative expression levels, corrected for the levels in NTG mice, are depicted for Col1a1, Col1a2, and Col3a1 procollagen genes.

 

Figure 4
View larger version (50K):

[in a new window]
 
Figure 4 Oxidized nuclear and mitochondrial DNA levels. (A) mtDNA isolated and digested with BamH1 restriction enzyme, which results in two bands of approximately 8 and 9 kbp, indicating the purity of the isolated mtDNA. (B) Immuno-slot blot of mtDNA (upper blot) and the corresponding ethidium bromide stained blot (lower blot) in three mice in each of the experimental groups. (C) Immuno-slot blot (upper blot) of nuclear DNA and ethidium bromide stained blot (lower blot) in three mice per experimental group.

 

Figure 5
View larger version (69K):

[in a new window]
 
Figure 5 Expression levels of selected signaling kinases. (A) Immunoblots showing expression levels of phosphorylated and total p44/42, p38, and JNK. (B, C, and D) Quantitative analysis of the relative levels of phosphorylated p44/42, p38, and JNK, respectively, all normalized to levels in the corresponding NTG group, in the experimental groups. The sum of density of 44 and 42 kDa bands were used to quantify levels of p44/42. Similarly, the sum density of 46 and 54 kDa bands were used for quantification of JNK. *p < 0.05 for pairwise comparisons.

 




 
  cardiology careers collections past issues search home